NasdaqCM - Delayed Quote USD

Elicio Therapeutics, Inc. (ELTX)

Compare
6.13
+0.46
+(8.11%)
At close: January 10 at 4:00:02 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
40,902.00
35,745.00
23,733.00
25,474.69
15,721.08
Operating Income
-40,902.00
-35,745.00
-23,733.00
-25,474.69
-15,721.08
Net Non Operating Interest Income Expense
-3,178.00
-686.00
-3,532.00
-873.05
8.94
Other Income Expense
-2,763.00
1,236.00
-943.00
-52.96
--
Pretax Income
-46,843.00
-35,195.00
-28,208.00
-26,400.70
-15,712.14
Net Income Common Stockholders
-46,843.00
-35,195.00
-28,208.00
-26,400.70
-15,712.14
Diluted NI Available to Com Stockholders
-46,843.00
-35,195.00
-28,208.00
-26,400.70
-15,712.14
Basic EPS
-3.44
-6.96
-2.70
-2.52
-1.93
Diluted EPS
-3.44
-6.96
-2.70
-2.52
-1.93
Basic Average Shares
10,926.07
5,056.23
10,463.80
10,463.80
8,146.76
Diluted Average Shares
10,926.07
5,056.23
10,463.80
10,463.80
8,146.76
Total Operating Income as Reported
-40,902.00
-35,745.00
-23,733.00
-25,474.69
-15,721.08
Total Expenses
40,902.00
35,745.00
23,733.00
25,474.69
15,721.08
Net Income from Continuing & Discontinued Operation
-46,843.00
-35,195.00
-28,208.00
-26,400.70
-15,712.14
Normalized Income
-44,080.00
-36,431.00
-27,265.00
-26,347.74
-15,712.14
Interest Income
547.00
373.00
65.00
3.39
8.94
Interest Expense
223.00
1,059.00
3,597.00
876.44
--
Net Interest Income
-3,178.00
-686.00
-3,532.00
-873.05
8.94
EBIT
-46,620.00
-34,136.00
-24,611.00
-25,524.26
-15,721.08
EBITDA
-45,461.00
-32,966.00
-23,554.00
-25,272.81
-15,527.65
Reconciled Depreciation
1,159.00
1,170.00
1,057.00
251.45
193.43
Net Income from Continuing Operation Net Minority Interest
-46,843.00
-35,195.00
-28,208.00
-26,400.70
-15,712.14
Total Unusual Items Excluding Goodwill
-2,763.00
1,236.00
-943.00
-52.96
--
Total Unusual Items
-2,763.00
1,236.00
-943.00
-52.96
--
Normalized EBITDA
-42,698.00
-34,202.00
-22,611.00
-25,219.84
-15,527.65
12/31/2020 - 2/5/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PHVS Pharvaris N.V.
17.80
-3.99%
 
CRGX CARGO Therapeutics, Inc.
13.50
-4.93%
 
CYCCP Cyclacel Pharmaceuticals, Inc.
7.60
-3.55%
 
ENGN enGene Holdings Inc.
7.61
-6.05%
 
ENTX Entera Bio Ltd.
2.4500
0.00%
 
GNFT Genfit S.A.
3.6000
0.00%
 
IPHA Innate Pharma S.A.
1.7700
-1.67%
 
ARVN Arvinas, Inc.
18.62
-6.05%
 
DMAC DiaMedica Therapeutics Inc.
5.27
-3.48%
 
ACOG Alpha Cognition Inc.
6.10
+6.56%